Nuveen Asset Management, LLC Enzo Biochem Inc Transaction History

Nuveen Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$2.86 - $3.61 $615,812 - $777,301	-215,319 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$2.61 - $4.08 $49,355 - $77,152	-18,910 Reduced 8.07%	215,319 $741,000
Q4 2020 Feb 16, 2021	SELL	$1.82 - $2.61 $9,327 - $13,376	-5,125 Reduced 2.14%	234,229 $590,000
Q3 2020 Nov 16, 2020	SELL	$2.02 - $3.02 $97,420 - $145,648	-48,228 Reduced 16.77%	239,354 $505,000
Q2 2020 Aug 14, 2020	BUY	$2.12 - $3.22 $252,481 - $383,485	119,095 Added 70.68%	287,582 $644,000
Q1 2020 May 14, 2020	SELL	$1.82 - $3.87 $90,858 - $193,198	-49,922 Reduced 22.86%	168,487 $426,000
Q4 2019 Feb 14, 2020	SELL	$2.57 - $3.68 $367,021 - $525,540	-142,810 Reduced 39.54%	218,409 $574,000
Q3 2019 Nov 14, 2019	BUY	$3.01 - $4.0 $432,094 - $574,212	143,553 Added 65.95%	361,219 $1.3 Million
Q2 2019 Aug 15, 2019	BUY	$2.79 - $4.31 $607,288 - $938,140	217,666 New	217,666 $733,000

15.5M

2.3K

Ticker ENZ
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 48,720,500
Market Cap $33.1M
Description
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.